GECPX — GMO Emerging Markets Series Fund

Data updated: 2021-01-29

GECPX — GMO Emerging Markets Series Fund. Money Market · $34.73M AUM · 0.99% expense ratio · 7.2% 1-yr return. Holdings, fees, performance and SEC filings.

GECPX Fund Overview

GECPX — GMO Emerging Markets Series Fund is a US mutual fund managed by GMO Series Trust, categorised as Money Market. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.

Type: US mutual fund
Manager: GMO Series Trust
Category: Money Market
Assets under management: $34.73M
1-year return: 7.2%
Ticker: GECPX
SEC CIK: 0001521894
SEC series ID: S000035227
Share class ID: C000174017

GECPX Investment Objective and Strategy

GMO Emerging Markets Series Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by GMO Series Trust.

Investment objective

Total return in excess of that of its benchmark, the MSCI Emerging Markets Index.

Principal investment strategy

The Fund invests substantially all of its assets in Class III shares of GMO Emerging Markets Fund (EMF), a series of GMO Trust not offered in this Prospectus. EMF invests in securities and other instruments. The Fund's investment objective and principal investment strategies are substantially similar to those of EMF. Except as otherwise indicated, references to the Fund may also refer to EMF, and references to actions undertaken or investments held by the Fund may also refer to those by EMF. GMO serves as investment adviser for both the Fund and EMF. The Fund typically invests directly and indirectly (e.g., through underlying funds or derivatives) in equities of companies tied economically to emerging markets. Emerging markets include all markets that are not treated as developed markets in the MSCI World Index or MSCI EAFE Index.

The term equities refers to direct and indirect investments in common and preferred stocks and other stock-related securities, such as convertible securities, depositary receipts, and equity real estate investment trusts (REITs) and income trusts. Under normal circumstances, the Fund invests directly and indirectly at least 80% of its assets in investments tied economically to emerging markets. In addition to investing in companies tied economically to emerging markets, the Fund may invest in companies that GMO believes are likely to benefit from growth in the emerging markets. GMO expects that the Fund will have a value bias relative to its benchmark. GMO uses proprietary quantitative techniques and fundamental analysis to evaluate and select countries, sectors, and equity investments based on factors including, but not limited to, valuation, quality, patterns of price movement and volatility, and macroeconomic factors.

In constructing the Fund's portfolio, GMO considers a number of factors, including the trade-off among forecasted returns, risk relative to the benchmark, transaction costs, and liquidity. GMO also adjusts the Fund's portfolio for factors such as position size, market capitalization, and exposure to particular industries, sectors, countries, regions, or currencies. At times, the Fund may have substantial exposure to a single asset class, industry, sector, country, region, or currency. The Fund may invest in securities of companies of any market capitalization. The factors GMO considers and investment methods GMO uses can change over time. As an alternative to investing directly in equities, the Fund may invest in exchange-traded and over-the-counter (OTC) derivatives and exchange-traded funds (ETFs).

The Fund also may invest in derivatives and ETFs in an attempt to obtain or adjust elements of its long or short investment exposure, and as a substitute for securities lending. Derivatives used may include options, futures, forward currency contracts, warrants, swap contracts, and reverse repurchase agreements. The Fund's foreign currency exposure may differ from the currency exposure represented by its equity investments. In addition, the Fund may overweight and underweight its positions in particular currencies relative to its benchmark. In addition, the Fund may lend its portfolio securities. The Fund also may invest in GMO U.S. Treasury Fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds. The Fund may hold cash, cash equivalents, and/or U.S.

government securities to manage cash inflows and outflows as a result of shareholder purchases and redemptions.

GECPX Performance

Total returns for GECPX (as of 2026-10-01), from SEC filings.

Period	Total return
1 year	7.2%

GECPX Risk Information

Risk metrics for GECPX, derived from monthly returns in SEC filings.

1-year volatility (annualised): 24.6%

GECPX Costs and Fees

GECPX costs about $99 per $10,000 invested per year in fund expenses.

Net expense ratio: 0.99%
Gross expense ratio: 1.18%
Portfolio turnover: 0%
Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)

GECPX Cashflows

Over the 12 months to 2020-11, GMO Emerging Markets Series Fund had net inflows of $7.52M, from monthly SEC N-PORT filings.

Month	Net flow
2020-11	−$109.29K
2020-10	$25.63K
2020-09	−$920.21K
2020-08	−$662.86K
2020-07	−$121.22K
2020-06	$62.10K

GECPX Debt Constituents

No individual debt constituents are reported in GMO Emerging Markets Series Fund's latest SEC N-PORT filing.

GECPX Prospectus and SEC Filings

Official GMO Emerging Markets Series Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.

Related Funds

Other Money Market funds tracked on ABC INVEST:

Data Sources

ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.